regulatory_update

Hong Kong – – September 11, 2026 -- RedotPay, a global stablecoin payments company, has received an independent review from a Big Four firm confirming that its AML/CFT controls can identify, assess, and manage financial crime risk.

Big Four review scrutinized two licensed Hong Kong subsidiaries

The review evaluated Red Dot Trust Limited and Red F. Technology Limited against AML/CFT guidelines issued by the Hong Kong Companies Registry. Its scope covered governance, quality assurance, customer due diligence, transaction monitoring, and internal staff training and resourcing.

Company projects $50 billion in stablecoin card spend by 2028

RedotPay expects stablecoin-powered cards to reach $50 billion in annualized spend by 2028 as stablecoin payments integrate further with card and financial-services infrastructure. The company frames the independent audit as a step to reinforce controls ahead of that projected scale.

Singapore – September 11, 2026 -- Parseur, an AI-powered document processing platform serving more than 10,000 businesses globally, has achieved SOC 2 Type II compliance following an independent audit by Constellation GRC, verified through Oneleet.

Audit confirms controls meet AICPA Trust Services Criteria after six-month review

The certification process took approximately six months and verified that Parseur's systems and controls consistently meet the American Institute of CPAs (AICPA) Trust Services Criteria for security, availability, and confidentiality. The report gives enterprise customers processing invoices, contracts, and financial records independently verified assurance over how their data is handled.

Berlin – September 11, 2026 -- Germany's Federal Medical Association (Bundesärztekammer) has confirmed support for a cross-sector reform of acute and emergency care, while pushing for amendments before the bill clears parliament.

Reinhardt calls for unified triage system across Germany

Association president Dr. Klaus Reinhardt told the Bundestag Health Committee ahead of a hearing on the draft law that the reform must introduce "genuine care management" needed across other healthcare sectors too. He said a nationwide, standardized initial assessment system is required to ensure patients are directed reliably through the system, with responsibility resting with physician self-governance bodies.

Berlin – September 11, 2026 -- The OECD's PISA 2025 study released today shows Germany's reading and math scores continuing to decline, prompting the SPD parliamentary group to push for expanded funding of its Startchancen-Programm and a new early-childhood quality law.

PISA 2025 shows Germany's core competencies eroding further

Saskia Esken, the SPD's rapporteur for school education, said Germany's school system delivers only middling results in international comparison, with performance in reading and math continuing to drop. She noted that social background determines educational success in Germany more strongly than in almost any other industrialized country, and that disadvantaged children are the ones falling furthest behind.

Hangzhou – September 11, 2026 -- HEVI Corp., a wholly owned subsidiary of Greenland Technologies Holding Corporation (NASDAQ: GTEC), has secured approval from the New York Vehicle Inspection Program (NYVIP) for two of its heavy electric industrial vehicles, opening access to state purchase incentives.

New York adds two HEVI loaders to its eligible equipment list

The H55L, a 5-ton electric loader, and the H65L, a 6.5-ton electric loader, are now listed under NYVIP's incentive-eligible equipment. Buyers who replace old equipment with these units can claim 35% of the base equipment cost, plus up to a $100,000 Disadvantaged Communities (DAC) bonus per unit.

Cambridge, Massachusetts – September 11, 2026 -- Harbour BioMed (HKEX: 02142) and partner Windward Bio reported positive Phase 2 interim results for HBM9378/WIN378, a twice-yearly TSLP-blocking antibody, from the 147-patient POLARIS-1 asthma trial, clearing the path for two Phase 3 studies.

Interim data show up to 174 mL lung-function gain after single dose

The Phase 2 interim analysis, conducted on the first 98 of 147 enrolled patients with uncontrolled moderate-to-severe asthma, found FEV1 increases of up to 174 mL, with a placebo-adjusted mean increase of 256 mL (p=0.033) at Week 24 after a single dose.

Biomarkers for airway inflammation drop sharply

FeNO fell by up to 24 ppb, a 43% reduction (p=0.006), while blood eosinophil counts dropped by up to 200 cells/μL, a 51% decline (p0.0001). Near-maximal effects appeared as early as Week 2 and were sustained through Week 24.

Houston – September 11, 2026 -- Cloverleaf Infrastructure LLC has signed the Michigan Affordability and Responsible Growth Pledge, joining Anthropic, Google, Microsoft, OpenAI and Oracle as signatories to the state's data center development framework.

Michigan Pledge Requires Developers to Secure New Energy Resources

The pledge, launched by Michigan Gov. Gretchen Whitmer, obligates signatories to ensure Michiganders do not face higher energy costs, to secure new energy resources to meet demand, and to fund necessary energy infrastructure upgrades. Signatories must also comply with environmental laws, prioritize local hiring and workforce development, and operate with transparency in project development and community investment.

Enschede -- Bizzdesign GovCloud achieved FedRAMP Certification on September 1, 2026, clearing the way for U.S. federal agencies to adopt the enterprise transformation SaaS provider's dedicated government offering.

Bizzdesign GovCloud enters the FedRAMP Marketplace with Alfabet as its first product

Bizzdesign GovCloud is now listed in the FedRAMP Marketplace, with Bizzdesign Alfabet as the initial product available through the certified environment. Alfabet provides strategic portfolio management, application portfolio management, and enterprise architecture capabilities aimed at managing complex federal IT estates.

Shanghai – September 11, 2026 -- Alebund Pharmaceuticals (Jiangsu) Limited (HKEX: 09637) has received U.S. FDA clearance of its Investigational New Drug application for AP308, a first-in-class engineered recombinant IgA protease targeting IgA Nephropathy (IgAN), moving the candidate from preclinical research into clinical development.

AP308 targets a disease affecting 9.5 million people worldwide

IgAN is the most common primary glomerulonephritis globally, with an estimated 9.5 million patients in 2025, including 5.1 million in China, more than half of the global total, according to China Insights Consultancy. Under current treatment strategies, median kidney survival is approximately 11 to 12 years, and roughly 60% of patients in a Chinese cohort progressed to end-stage renal disease within 15 years of diagnosis, per long-term studies in China and the UK.

Hamburg – September 11, 2026 -- Hamburg's Senate has approved the procedural framework for a new Asklepios Klinik Altona, clearing the way for a Europe-wide tender to build a 600-bed hospital serving more than 280,000 residents in western Hamburg.

Senate clears path for continent-wide procurement process

The city's Social Affairs Authority and Asklepios have agreed on key parameters covering planning and construction awards, project financing, supporting infrastructure and land provision. The Hamburg parliament (Bürgerschaft) will decide on final construction and equipment costs once tender results are in, with a vote expected by the end of 2027.